Oral Ifetroban in Patients With Idiopathic Pulmonary Fibrosis (IPF)
A Randomized, Double-Blind, Placebo-Controlled Phase II Study With an Open-Label Extension to Determine the Safety and Efficacy of Oral Ifetroban in Patients With Idiopathic Pulmonary Fibrosis (IPF) A Randomized, Double-Blind, Placebo-Controlled Phase II Study With an Open-Label Extension to Determ ...